nach oben

Supportive Care in Cancer

Erschienen in:

05.01.2021 | Review Article

Self-efficacy in symptom management for adolescents and young adults with cancer: a systematic review

verfasst von: Clifton P. Thornton, Mengchi Li, Chao Hsing Yeh, Kathy Ruble

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Adolescents and young adults (AYAs) have more frequent and intense adverse effects from cancer therapy than other age groups. Self-efficacy, the ability for persons to maintain health-related behavior change, may assist with symptom management but the role it plays in AYAs with cancer has not been thoroughly investigated. This review explores the role that self-efficacy has in symptom management for AYAs with cancer and provides guidance for clinicians to utilize self-efficacy as a means to reduce side effects of therapy.

Methods

A systematic review of peer-reviewed literature was conducted to identify works discussing self-efficacy and symptom management for AYAs with cancer. Five databases were searched with key terms and articles that discussed relationships between self-efficacy and cancer therapy symptoms were retained for analysis.

Findings

Twelve manuscripts representing 1180 individuals age 12 to 43 years were identified. Self-efficacy was found to be related to (1) health management behaviors, (2) psychosocial health, (3) sexual and reproductive health, and (4) physical symptoms. Self-efficacy had direct correlations with physical activity, nutritional intake, symptom regulation, mental health, sexual health, and fertility preservation. The included studies did not find significant relationships with medication adherence or pain management.

Discussion

Self-efficacy is an attribute that impacts behavior change, health maintenance, and overall wellness and can be changed over time and through interventions to improve symptoms of cancer therapy. Self-efficacy should be evaluated as a construct in relevant studies aimed at improving side effects of cancer therapy to better understand outcomes from interventions. Symptoms, toxicities, and adverse effects of cancer therapy may be improved by increasing self-efficacy of patients.

Bukowinski AJ, Burns KC, Parsons K, Perentesis JP, O’Brien MM (2015) Toxicity of cancer therapy in adolescents and young adults (AYAs). Semin Oncol Nurs 31(3):216–226. https://doi.org/10.1016/j.soncn.2015.05.003CrossRefPubMed

Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui CH, Evans WE (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12(8):1667–1672. https://doi.org/10.1200/JCO.1994.12.8.1667CrossRefPubMed

Larsen EC, Devidas M, Chen S, Salzer WL, Raetz EA, Loh ML, Mattano LA Jr, Cole C, Eicher A, Haugan M, Sorenson M, Heerema NA, Carroll AA, Gastier-Foster JM, Borowitz MJ, Wood BL, Willman CL, Winick NJ, Hunger SP, Carroll WL (2016) Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children’s oncology group study AALL0232. J Clin Oncol 34(20):2380–2388. https://doi.org/10.1200/JCO.2015.62.4544CrossRefPubMedPubMedCentral

Canner JA, Alonzo TA, Franklin J, Freyer DR, Gamis AS, Gerbing RB, Lange B, Meshinchi S, Woods WG, Perentesis JP, Horan J (2011) Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML. J Clin Oncol 29(15):9506. https://doi.org/10.1200/jco.2011.29.15_suppl.9506CrossRef

Franklin ARK, Alonzo TA, Gerbing RB, Donohue K, Othus M, Horan J, Estey EH, Larson RA, Woods WG (2010) Outcome of adolescents and young adults (AYAs) with non-M3 acute myeloid leukemia (AML) treated on children’s oncology group (COG) trials compared to cancer and leukemia group B (CALGB) and southwest oncology group (SWOG) trials. Blood. 116(21):183CrossRef

Freyer DR, Felgenhauer J, Perentesis J, on behalf of the COG Adolescent and Young Adult Oncology, Discipline Committee (2013) Children’s oncology group’s 2013 blueprint for research: adolescent and young adult oncology. Pediatrirc Blood and Cancer 60(6):1055–1058. https://doi.org/10.1002/pbc.24431CrossRef

Zebrack B, Kent EE, Keegan THM, Kato I, Smith AW, Aya Hope Study Collaborative, Group 1 (2014) “Cancer sucks,” and other ponderings by adolescent and young adult cancer survivors. J Psychosoc Oncol 32(1):1–15. https://doi.org/10.1080/07347332.2013.855959CrossRefPubMedPubMedCentral

Patterson P, McDonald FEJ, Zebrack B, Medlow S (2015) Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs 31(1):53–59. https://doi.org/10.1016/j.soncn.2014.11.006CrossRefPubMed

American Cancer Society. Adolescents and young adults with cancer. Retreived from https://www.cancer.gov/types/aya. Accessed on 7/25/2020. Updated 2018

10.

Dalal S, Bruera E (2017) End-of-life care matters: palliative cancer care results in better care and lower costs. Oncologist 22(4):361–368. https://doi.org/10.1634/theoncologist.2016-0277CrossRefPubMedPubMedCentral

11.

White LL, Cohen MZ, Berger AM, Kupzyk KA, Swore-Fletcher BA, Bierman PJ (2017) Perceived self-efficacy: a concept analysis for symptom management in patients with cancer. Clin J Oncol Nurs 21(6):E272–E279. https://doi.org/10.1188/17.CJON.E272-E279CrossRefPubMed

12.

Bandura A (1982) Self-efficacy mechanism in human agency. Am Psychol 72(2):122–147. https://doi.org/10.1037/0003-066X.37.2.122CrossRef

13.

Victor JS, Brenda MEDV et al (1986) The role of self-efficacy in achieving health. Health Education & Behavior 13(1). https://doi.org/10.1177/109019818601300108

14.

Ebrahimi Belil F, Alhani F, Ebadi A, Kazemnejad A (2018) Self-efficacy of people with chronic conditions: a qualitative directed content analysis. J Clin Med 7(11):411. https://doi.org/10.3390/jcm7110411CrossRefPubMedCentral

15.

Sodergren SC, Husson O, Robinson J et al (2017) Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer. Qual Life Res 26(7):1659–1672. https://doi.org/10.1007/s11136-017-1520-xCrossRefPubMedPubMedCentral

16.

Levine DR, Liederbach E, Johnson L et al (2019) Are we meeting the informational needs of cancer patients and families? Perception of physician communication in pediatric oncology. Cancer. 125(9):1518–1526. https://doi.org/10.1002/cncr.31937CrossRefPubMedPubMedCentral

17.

McLaughlin CA, Gordon K, Hoag J et al (2019) Factors affecting adolescents’ willingness to communicate symptoms during cancer treatment: a systematic review from the children’s oncology group. Journal of Adolescent and Young Adult Oncology. 8(2):15–113. https://doi.org/10.1089/jayao.2018.0111CrossRef

18.

Leahy AB, Feudtner C, Basch E (2017) Symptom monitoring in pediatric oncology using patient-reported outcomes: why, how, and where next. Patient. 11(2):147–153. https://doi.org/10.1007/s40271-017-0279-zCrossRef

19.

Howell D, Harth T, Brown J, Bennett C, Boyko S (2017) Self-management education interventions for patients with cancer: a systematic review. Support Care Cancer 25(4):1323–1355. https://doi.org/10.1007/s00520-016-3500-zCrossRefPubMed

20.

Zebrack BJ, Corbett V, Embry L, Aguilar C, Meeske KA, Hayes-Lattin B, Block R, Zeman DT, Cole S (2014) Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis. Psychooncology. 23(11):1267–1275CrossRef

21.

Chirico A, Lucidi F, Merluzzi T et al (2017) A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life. Oncotarget 8(22):36800–36811. https://doi.org/10.18632/oncotarget.15758CrossRefPubMedPubMedCentral

22.

White LL, Cohen MZ, Berger AM, Kupzyk KA, Bierman PJ (2019) Self-efficacy for management of symptoms and symptom distress in adults with cancer: an integrative review. Oncol Nurs Forum 46(1):113–128. https://doi.org/10.1188/19.ONF.113-128CrossRefPubMed

23.

Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC (2018) The age of adolescence. The Lancet Child & Adolescent Health 2(3):223–228. https://doi.org/10.1016/S2352-4642(18)30022-1CrossRef

24.

Pugh G, Petrella A, Fisher A, Reynolds J, Epstone S (2019) Trekstock meet & move: the impact of one-day health and well-being events for young adults with cancer. Journal of Adolescent and Young Adult Oncology 9(2):278–285. https://doi.org/10.1089/jayao.2019.0108CrossRefPubMed

25.

Dearholt S, Dang D (2012) Johns Hopkins nursing evidence-based practice : model and guidelines. Indianapolis, Sigma Theta Tau International

26.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 336(7650):924–926. https://doi.org/10.1136/bmj.39489.470347.ADCrossRef

27.

Dahm P, Guyatt G, Schünemann HJ et al (2011) GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026CrossRefPubMed

28.

Kato P, Cole S, Bradlyn A, Pollock B (2008) A video game improves behavioral outcomes in adolescents and young adults with cancer: a randomized trial. Pediatrics. 122(2):305–e317. https://doi.org/10.1542/peds.2007-3134CrossRef

29.

Klosky JL, Lehmann V, Flynn JS, Su Y, Zhang H, Russell KM, Schenck LAM, Schover LR (2018) Patient factors associated with sperm cryopreservation among at-risk adolescents newly diagnosed with cancer. Cancer. 124(17):3567–3575. https://doi.org/10.1002/cncr.31596CrossRefPubMedPubMedCentral

30.

Diorio C, Lin M, Ginn E, Ladas EJ (2018) Psychosocial determinants of physical activity and dietary behaviors in adolescents and young adults with cancer and survivors. Pediatric Blood & Cancer 65(9):e27243-n/a. https://doi.org/10.1002/pbc.27243CrossRef

31.

Wu W, Yu T, Jou S, Hung G (2019) Physical activity self-efficacy mediates the effect of symptom distress on exercise involvement among adolescents undergoing cancer treatment. European Journal of Cancer Care 28(4):e13045-n/a. https://doi.org/10.1111/ecc.13045CrossRef

32.

Hullmann SE, Brumley LD, Schwartz LA (2014) Medical and psychosocial associates of nonadherence in adolescents with cancer. J Pediatr Oncol Nurs 32(2):103–113. https://doi.org/10.1177/1043454214553707CrossRefPubMedPubMedCentral

33.

Erickson JM, Ameringer S, Linder L, Macpherson CF, Elswick RK Jr, Luebke JM, Stegenga K (2019) Using a heuristic app to improve symptom self-management in adolescents and young adults with cancer. Journal of Adolescent and Young Adult Oncology. 8(2):131–141. https://doi.org/10.1089/jayao.2018.0103CrossRefPubMed

34.

Aubin S, Rosberger Z, Petr K, Gerald B, Hafez N (2014) Cancer! I don’t have time for that. Using Skype technology to help young adults adjust to the repercussions of cancer. Psycho-oncology. 23:173–254. https://doi.org/10.1111/j.1099-1611.2014.3695CrossRef

35.

Zebrack B, Kwak M, Sundstrom L (2017) First descents, an adventure program for young adults with cancer: who benefits? Support Care Cancer 25(12):3665–3673. https://doi.org/10.1007/s00520-017-3792-7CrossRefPubMed

36.

Rosenberg AR, Bradford M, Bona KO et al (2015) Screening for self-efficacy and distress: a report from the “Resilience in adolescents and young adults with cancer” study. Journal of Clinical Oncology 33(15, suppl):e21037. https://doi.org/10.1200/jco.2015.33.15_suppl.e21037CrossRef

37.

Hinds P, Quargnenti A, Bush A et al (2000) An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. Eur J Oncol Nurs 4(1):6–17; 18. https://doi.org/10.1054/ejon.1999.0051CrossRefPubMed

38.

Jibb LA, Stevens BJ, Nathan PC et al (2017) Implementation and preliminary effectiveness of a real-time pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study. Pediatric Blood & Cancer 64(10):e26554-n/a. https://doi.org/10.1002/pbc.26554CrossRef

39.

Ruble K, Li HCW, Thornton CP, Hooke MC (2020) Exercise and physical activity. In: Hinds P, Linder L (eds) Pediatric oncology nursing: defining care through science. Springer, pp 153–167

40.

Poitras VJ, Gray CE, Borghese MM, Carson V, Chaput JP, Janssen I, Katzmarzyk PT, Pate RR, Connor Gorber S, Kho ME, Sampson M, Tremblay MS (2016) Systematic review of the relationships between objectively measured physical activity and health indicators in school-aged children and youth. Appl Physiol Nutr Metab 41(6):S197–S239. https://doi.org/10.1139/apnm-2015-0663CrossRefPubMed

41.

Carson V, Hunter S, Kuzik N, Wiebe SA, Spence JC, Friedman A, Tremblay MS, Slater L, Hinkley T (2016) Systematic review of physical activity and cognitive development in early childhood. J Sci Med Sport 19(7):573–578. https://doi.org/10.1016/j.jsams.2015.07.011CrossRefPubMed

42.

Götte M, Kesting S, Winter C, Rosenbaum D, Boos J (2014) Experience of barriers and motivations for physical activities and exercise during treatment of pediatric patients with cancer. Pediatr Blood Cancer 61(9):1632–1637. https://doi.org/10.1002/pbc.25071CrossRefPubMed

43.

Nielsen MKF, Christensen JF, Frandsen TL, Thorsteinsson T, Andersen LB, Christensen KB, Nersting J, Faber M, Schmiegelow K, Larsen HB (2018) Testing physical function in children undergoing intense cancer treatment—a RESPECT feasibility study. Pediatr Blood Cancer 65(8):e27100. https://doi.org/10.1002/pbc.27100CrossRefPubMed

44.

Hooke MC, Garwick AW, Neglia JP (2013) Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer. Cancer Nurs 36(5):E9–E16. Accessed 15 Aug 2020. https://doi.org/10.1097/NCC.0b013e31829f5510CrossRefPubMed

45.

Ward-Smith P, Hamlin J, Bartholomew J, Stegenga K (2007) Quality of life among adolescents with cancer. J Pediatr Oncol Nurs 24(3):166–171. https://doi.org/10.1177/1043454207299656CrossRefPubMed

46.

Baumann FT, Bloch W, Beulertz J (2013) Clinical exercise interventions in pediatric oncology: a systematic review. Pediatr Res 74(4):366–374. https://doi.org/10.1038/pr.2013.123CrossRefPubMed

47.

Thornton CP, Ruble K, Kozachik S (2020. (in press)) Psychosocial interventions for adolescents and young adults with cancer: an integrative review. Journal of Pediatric Oncology Nursing 37:408–422. https://doi.org/10.1177/1043454220919713CrossRefPubMed

48.

Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA (2018) Adolescent and young adult oncology, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 16(1):66–97CrossRef

49.

Warner EL, Kent EE, Trevino KM, Parsons HM, Zebrack BJ, Kirchhoff AC (2016) Social well-being among adolescents and young adults with cancer: a systematic review. Cancer. 122(7):1029–1037. https://doi.org/10.1002/cncr.29866CrossRefPubMedPubMedCentral

50.

Stinson JN, Jibb LA, Greenberg M, Barrera M, Luca S, White ME, Gupta A (2015) A qualitative study of the impact of cancer on romantic relationships, sexual relationships, and fertility: perspectives of Canadian adolescents and parents during and after treatment. Journal of Adolescent and Young Adult Oncology. 4(2):84–90. https://doi.org/10.1089/jayao.2014.0036CrossRefPubMed

51.

Geue K, Schmidt R, Sender A, Sauter S, Friedrich M (2015) Sexuality and romantic relationships in young adult cancer survivors: satisfaction and supportive care needs. Psycho-oncology (Chichester, England) 24(11):1368–1376. https://doi.org/10.1002/pon.3805CrossRef

52.

Robinson L, Miedema B, Easley J (2014) Young adult cancer survivors and the challenges of intimacy. J Psychosoc Oncol 32(4):447–462. https://doi.org/10.1080/07347332.2014.917138CrossRefPubMed

53.

Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, Melisko ME, Cedars MI, Rosen MP (2012) Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 118(6):1710–1717. https://doi.org/10.1002/cncr.26459CrossRefPubMed

54.

Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, Daw N, Morris EB, Hudson MM (2009) Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol 26(4):252–260. https://doi.org/10.1080/08880010902901294CrossRefPubMedPubMedCentral

55.

Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM, Mascarenhas L, Ritchey AK, Casillas JN, Dickens DS, Meza J, Carroll WL, Relling MV, Wong FL (2012) Nonadherence to oral mercaptopurine and risk of relapse in hispanic and non-hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol 30(17):2094–2101. https://doi.org/10.1200/jco.2011.38.9924CrossRefPubMedPubMedCentral

56.

Bleyer A (2007) Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57(4):242–255 57/4/242CrossRef

57.

Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. Am J Health Promot 12(1):38–48. https://doi.org/10.4278/0890-1171-12.1.38CrossRefPubMed

Titel: Self-efficacy in symptom management for adolescents and young adults with cancer: a systematic review
verfasst von: Clifton P. Thornton
Mengchi Li
Chao Hsing Yeh
Kathy Ruble
Publikationsdatum: 05.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 6/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-020-05960-6

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Self-efficacy in symptom management for adolescents and young adults with cancer: a systematic review

Abstract

Background

Methods

Findings

Discussion

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

CAR-M-Zellen: Warten auf das große Fressen

Blutdrucksenkung könnte Uterusmyome verhindern

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Findings

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2021

Correction to: Patient and family financial burden associated with cancer treatment in Canada: a national study

Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors

Physical exercise during adjuvant chemotherapy for colorectal cancer—a non-randomized feasibility study

Neurocognitive impairment following proton therapy for paediatric brain tumour: a systematic review of post-therapy assessments

The impact of timing and modalities of dental prophylaxis on the risk of 5-fluorouracil–related oral mucositis in patients with head and neck cancer: a nationwide population-based cohort study

MyPref: pilot study of a novel communication and decision-making tool for adolescents and young adults with advanced cancer

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

CAR-M-Zellen: Warten auf das große Fressen

Blutdrucksenkung könnte Uterusmyome verhindern

Update Onkologie